AKAN: Akanda Corp. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 1.70
Enterprise Value ($M) 1.70
Book Value ($M) 0.00
Book Value / Share 0.00
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets 0.00
Assets 0.00
Liabilities 0.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 4,743 23,601 20.10
2025-04-16 39,694 76,327 52.01
2025-04-15 1,552 8,533 18.19

(click for more detail)

Similar Companies
ADVM – Adverum Biotechnologies, Inc. AGEN – Agenus Inc.
AIMD – Ainos, Inc. AKBA – Akebia Therapeutics, Inc.
ALBT – Avalon GloboCare Corp.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.